Immunovent Revenue and Competitors
Estimated Revenue & Valuation
- Immunovent's estimated annual revenue is currently $775k per year.
- Immunovent's estimated revenue per employee is $155,000
Employee Data
- Immunovent has 5 Employees.
- Immunovent grew their employee count by -17% last year.
Immunovent's People
| Name | Title | Email/Phone |
|---|
Immunovent Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Immunovent?
Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing clinical practices with our patented LAMB-Dx test. The Local Allergy Mucosal Brush test (LAMB-Dx) detects small amounts of antigen-specific IgE from symptomatic areas of the body, such as the mouth and the nose. Through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay, LAMB-Dx seeks to rapidly and safely diagnose common allergies without the inconvenience and issues of conventional skin prick and blood testing.
keywords:N/A
N/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 5 | 0% | $46.6M |
#2 | $0.4M | 5 | 0% | N/A |
#3 | $0.4M | 5 | 0% | N/A |
#4 | $0.1M | 5 | -55% | $20M |
#5 | $0.1M | 5 | N/A | $12M |